SCHEMBL5134555

SCHEMBL5134555

C=CC(N)OC(=O)C1=CNC=C(C(=O)O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584416 0.73 TSHR (0.38)
SCHEMBL10699564 0.73 CYP3A4 (0.44)
SCHEMBL5586542 0.71 PTPN1 (0.31)
Hydrochloric Acid SCHEMBL7212773 0.71 BLM (0.40)
SCHEMBL9806461 0.68 TSHR (0.34)
SCHEMBL1493619 0.66 TSHR (0.53)
SCHEMBL1489814 0.63
SCHEMBL11869445 0.62
SCHEMBL156789 0.61 TSHR (0.34)
SCHEMBL15877804 0.60 TSHR (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080152640-A1 Means and Methods For Treating a Disease Which is Associated With an Excess Transport of Hyaluronan Across a Lipid Bilayer UNIVERSITATSKLINIKUM MUNSTER (DE) 2008-06-26 US disclosed
EP-1660072-A2 MEANS AND METHODS FOR TREATING A DISEASE WHICH IS ASSOCIATED WITH AN EXCESS TRANSPORT OF HYALURONAN ACROSS A LIPID BILAYER Universitätsklinikum Münster (DE) 2006-05-31 EP disclosed
WO-2005013947-A2 MEANS AND METHODS FOR TREATING A DISEASE WHICH IS ASSOCIATED WITH AN EXCESS TRANSPORT OF HYALURONAN ACROSS A LIPID BILAYER Universitätsklinikum Münster (DE) 2005-02-17 WO disclosed